Prophylactic Scopolamine Butylbromide and Death Rattle in Patients at the End of Life - Reply

Harriette J. Van Esch; Lia Van Zuylen; Carin C.D. Van Der Rijt

doi:10.1001/jama.2021.21863

Prophylactic Scopolamine Butylbromide and Death Rattle in Patients at the End of Life - Reply

Harriette J. Van Esch^*, Lia Van Zuylen, Carin C.D. Van Der Rijt

^*Corresponding author for this work

Medical Oncology

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	285-286
Number of pages	2
Journal	JAMA - Journal of the American Medical Association
Volume	327
Issue number	3
DOIs	https://doi.org/10.1001/jama.2021.21863
Publication status	Published - 18 Jan 2022

Bibliographical note

Funding Information:
Conflict of Interest Disclosures: Dr van Esch reported receiving grants from Laurens Zorg in Balans during the conduct of the study. Dr van Zuylen reported receiving grants from the Netherlands Organization for Health Research and Development (ZonMw). Dr van der Rijt reported receiving grants from the ZonMw and Stichting Voorzieningenfonds Calando and serving as a consultant to Kyowa Kirin and Ipsen Pharmaceutica BV.

Access to Document

10.1001/jama.2021.21863Licence: Unspecified

Cite this

@article{38027fab1fbf456aaa934d99ccb78564,

title = "Prophylactic Scopolamine Butylbromide and Death Rattle in Patients at the End of Life - Reply",

author = "{Van Esch}, {Harriette J.} and {Van Zuylen}, Lia and {Van Der Rijt}, {Carin C.D.}",

note = "Funding Information: Conflict of Interest Disclosures: Dr van Esch reported receiving grants from Laurens Zorg in Balans during the conduct of the study. Dr van Zuylen reported receiving grants from the Netherlands Organization for Health Research and Development (ZonMw). Dr van der Rijt reported receiving grants from the ZonMw and Stichting Voorzieningenfonds Calando and serving as a consultant to Kyowa Kirin and Ipsen Pharmaceutica BV.",

year = "2022",

month = jan,

day = "18",

doi = "10.1001/jama.2021.21863",

language = "English",

volume = "327",

pages = "285--286",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "3",

}

TY - JOUR

T1 - Prophylactic Scopolamine Butylbromide and Death Rattle in Patients at the End of Life - Reply

AU - Van Esch, Harriette J.

AU - Van Zuylen, Lia

AU - Van Der Rijt, Carin C.D.

N1 - Funding Information: Conflict of Interest Disclosures: Dr van Esch reported receiving grants from Laurens Zorg in Balans during the conduct of the study. Dr van Zuylen reported receiving grants from the Netherlands Organization for Health Research and Development (ZonMw). Dr van der Rijt reported receiving grants from the ZonMw and Stichting Voorzieningenfonds Calando and serving as a consultant to Kyowa Kirin and Ipsen Pharmaceutica BV.

PY - 2022/1/18

Y1 - 2022/1/18

UR - http://www.scopus.com/inward/record.url?scp=85123381624&partnerID=8YFLogxK

U2 - 10.1001/jama.2021.21863

DO - 10.1001/jama.2021.21863

M3 - Comment/Letter to the editor

C2 - 35040890

AN - SCOPUS:85123381624

SN - 0098-7484

VL - 327

SP - 285

EP - 286

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 3

ER -

Prophylactic Scopolamine Butylbromide and Death Rattle in Patients at the End of Life - Reply

Bibliographical note

Access to Document

Other files and links

Cite this